Cargando…

Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)

INTRODUCTION: Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. The primary aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ainsworth, James, Sewell, Peter, Eggert, Sabine, Morris, Keith, Pillai, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505078/
https://www.ncbi.nlm.nih.gov/pubmed/37720488
http://dx.doi.org/10.1155/2023/4037915
_version_ 1785106842027819008
author Ainsworth, James
Sewell, Peter
Eggert, Sabine
Morris, Keith
Pillai, Suresh
author_facet Ainsworth, James
Sewell, Peter
Eggert, Sabine
Morris, Keith
Pillai, Suresh
author_sort Ainsworth, James
collection PubMed
description INTRODUCTION: Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. The primary aim of this study was to establish the incidence of secondary fungal infections in patients admitted to the ICU with COVID-19. Secondary aims were to investigate factors that may contribute to an increased risk of fungal infections and to calculate the mortality between fungal and nonfungal groups. METHODS: We undertook a retrospective observational study in a tertiary ICU in Wales, United Kingdom. 174 patients admitted with COVID-19 infection from March 2020 until May 2021 were included. Data were collected through a retrospective review of patient's clinical notes and microbiology investigation results obtained from the online clinical portal. RESULTS: 81/174 (47%) COVID-19 patients developed fungal infections, 93% of which were Candida species, including Candida albicans (88%), and 6% had an Aspergillus infection. Age and smoking history did not appear to be contributing factors. The nonfungal group had a significantly higher body mass index (33 ± 8 vs. 31 ± 7, p=0.01). The ICU length of stay (23 (1–116) vs. 8 (1–60), p < 0.001), hospital length of stay (30 (3–183) vs. 15 (1–174) ± 7, p < 0.001), steroid days (10 (1–116) vs. 4 (0–28), p=0.02), and ventilation days (18 (0–120) vs. 2 (0–55), p < 0.001) were significantly higher in the fungal group. The mortality rate in both groups was similar (51% vs. 52%). The Kaplan–Meier survival analysis showed that the fungal group survived more than the nonfungal group (log rank (Mantel–Cox), p < 0.001). CONCLUSION: Secondary fungal infections are common in COVID-19 patients admitted to the ICU. Longer treatment with corticosteroids, increased length of hospital and ICU stay, and greater length of mechanical ventilation significantly increase the risk of fungal infections. Fungal infection, however, was not associated with an increase in mortality.
format Online
Article
Text
id pubmed-10505078
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105050782023-09-17 Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU) Ainsworth, James Sewell, Peter Eggert, Sabine Morris, Keith Pillai, Suresh Crit Care Res Pract Research Article INTRODUCTION: Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. The primary aim of this study was to establish the incidence of secondary fungal infections in patients admitted to the ICU with COVID-19. Secondary aims were to investigate factors that may contribute to an increased risk of fungal infections and to calculate the mortality between fungal and nonfungal groups. METHODS: We undertook a retrospective observational study in a tertiary ICU in Wales, United Kingdom. 174 patients admitted with COVID-19 infection from March 2020 until May 2021 were included. Data were collected through a retrospective review of patient's clinical notes and microbiology investigation results obtained from the online clinical portal. RESULTS: 81/174 (47%) COVID-19 patients developed fungal infections, 93% of which were Candida species, including Candida albicans (88%), and 6% had an Aspergillus infection. Age and smoking history did not appear to be contributing factors. The nonfungal group had a significantly higher body mass index (33 ± 8 vs. 31 ± 7, p=0.01). The ICU length of stay (23 (1–116) vs. 8 (1–60), p < 0.001), hospital length of stay (30 (3–183) vs. 15 (1–174) ± 7, p < 0.001), steroid days (10 (1–116) vs. 4 (0–28), p=0.02), and ventilation days (18 (0–120) vs. 2 (0–55), p < 0.001) were significantly higher in the fungal group. The mortality rate in both groups was similar (51% vs. 52%). The Kaplan–Meier survival analysis showed that the fungal group survived more than the nonfungal group (log rank (Mantel–Cox), p < 0.001). CONCLUSION: Secondary fungal infections are common in COVID-19 patients admitted to the ICU. Longer treatment with corticosteroids, increased length of hospital and ICU stay, and greater length of mechanical ventilation significantly increase the risk of fungal infections. Fungal infection, however, was not associated with an increase in mortality. Hindawi 2023-09-09 /pmc/articles/PMC10505078/ /pubmed/37720488 http://dx.doi.org/10.1155/2023/4037915 Text en Copyright © 2023 James Ainsworth et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ainsworth, James
Sewell, Peter
Eggert, Sabine
Morris, Keith
Pillai, Suresh
Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)
title Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)
title_full Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)
title_fullStr Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)
title_full_unstemmed Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)
title_short Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU)
title_sort fungal infections are not associated with increased mortality in covid-19 patients admitted to intensive care unit (icu)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505078/
https://www.ncbi.nlm.nih.gov/pubmed/37720488
http://dx.doi.org/10.1155/2023/4037915
work_keys_str_mv AT ainsworthjames fungalinfectionsarenotassociatedwithincreasedmortalityincovid19patientsadmittedtointensivecareuniticu
AT sewellpeter fungalinfectionsarenotassociatedwithincreasedmortalityincovid19patientsadmittedtointensivecareuniticu
AT eggertsabine fungalinfectionsarenotassociatedwithincreasedmortalityincovid19patientsadmittedtointensivecareuniticu
AT morriskeith fungalinfectionsarenotassociatedwithincreasedmortalityincovid19patientsadmittedtointensivecareuniticu
AT pillaisuresh fungalinfectionsarenotassociatedwithincreasedmortalityincovid19patientsadmittedtointensivecareuniticu